Ключевые слова
Как цитировать
Аннотация
В рамках представленного клинического наблюдения у одного пациента мы последовательно столкнулись с актуальными вопросами торакальной онкологии: корректное стадирование и лечение НМРЛ IIIA стадии с использованием видеомедиастиноскопии, неоадъювантная иммунотерапия с феноменом псевдопрогрессирования, ВТС сегментэктомия при периферическом НМРЛ IA стадии с хорошим непосредственным и среднесрочным результатом.
Библиографические ссылки
Tsitsias T., Boulemden A., Ang K. et al. The N2 paradox: similar out-comes of pre- and postoperatively identified single-zone N2a positive non-small-cell lung cancer. Eur J Cardiothorac Surg 2014; 45: 882-887.
van Meerbeeck J.P., Kramer G.W., Van Schil P.E. et al. Randomized controlled trial of resection versus radio therapy after induction chemotherapy in stage IIIA-N2 non-small-cell lung cancer. J Natl Cancer Inst 2007; 99: 442-450.
Барчук А.С., Левченко Е.В., Арсеньев А.И. и др. Актуальные вопросы комбинированного лечения рака легкого. Вопросы онкологии; 2012. Т. 58. № 2. С. 253259.
National Comprehensive Cancer Network. Lung cancer (2019). Version 7.2019, 10/10/19 https://www.nccn.org/ professionals/physician_gls/pdf
Postmus P.E., Kerr K.M., Oudkerk M. et al. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology. 2017, Volume 28, Issue suppl_4, Pages iv1-iv21.
Chaft Jamie E., Valerie Rusch, Michelle S. Ginsberg et al. Phase II Trial of Neoadjuvant Bevacizumab Plus Chemotherapy and Adjuvant Bevacizumab in Patients with Resectable Nonsquamous Non-Small-Cell Lung Cancers. Journal of Thoracic Oncology. 2013. 8, no. 8: 1084-1090. DOI: 10.1097/jto.0b013e31829923ec
Provencio-Pulla Mariano, Ernest Nadal-Alforja, Manuel Cobo et al. Neoadjuvant Chemo/immunotherapy for the Treatment of Stages IIIA Resectable Non-Small Cell Lung Cancer (NSCLC): A Phase II Multicenter Exploratory study-NADIM Study-SLCG. Journal of Clinical Oncology. 2018, 36, no. 15_suppl: 8521-8521.
Bott Matthew J., Stephen C. Yang, Bernard J. Park et al. Initial Results of Pulmonary Resection after Neoadjuvant Nivolumab in Patients with Resectable Non-small Cell Lung Cancer. The Journal of Thoracic and Cardiovascular Surgery. 2019, 158, no. 1: 269-276. DOI: 10.1016/j.jtcvs.2018.11.124
Blasberg Justin D., Harvey I. Pass, Jessica S. Donington. Sublobar Resection: A Movement from the Lung Cancer Study Group. Journal of Thoracic Oncology. 2010, 5, no. 10: 1583-1593.
Nakamura K., H. Saji, R. Nakajima et al. A Phase III Randomized Trial of Lobectomy Versus Limited Resection for Small-Sized Peripheral Non-Small Cell Lung Cancer (JCOG0802/WJOG4607L). Japanese Journal of Clinical Oncology. 2009, 40, no. 3: 271-274.
Merlano Marco, Marcella Occelli, Ornella Garrone. Immune-Related Response Criteria: Light and Shadows. ESMO Open. 2016, 1, no. 4: e000082. DOI: 10.1136/es-moopen-2016-000082
Hochmair Maximilian J., Sophia Schwab, Otto C. Burghuber et al. Symptomatic Pseudo-Progression Followed by Significant Treatment Response in Two Lung Cancer Patients Treated with Immunotherapy. Lung Cancer. 2017, 113: 4-6. DOI: 10.1016/j.lungcan.2017.08.020
Mayoral M., Castaner E., Gallardo X. et al. Pseudoprogresion Tumoral En El Tratamiento Inmunoterapico Con Nivolumab En El Cancer de Pulmon. Radiologia. 2019. DOI: 10.1016/j.rx.2019.05.004
Veluswamy Rajwanth R., Nicole Ezer, Grace Mhango et al. Limited Resection Versus Lobectomy for Older Patients With Early-Stage Lung Cancer: Impact of Histology. Journal of Clinical Oncology. 2015, 33, no. 30: 3447-3453. DOI: 10.1200/jco.2014.60.6624
Koike Terumoto, Akihiko Kitahara, Seijiro Sato et al. Lobectomy Versus Segmentectomy in Radiologically Pure Solid Small-Sized Non-Small Cell Lung Cancer. The Annals of Thoracic Surgery. 2016, 101, no. 4: 1354-1360. DOI: 10.1016/j.athoracsur.2015.10.048
Yang Jie, Ming Liu, Jie Fan et al. Surgical Treatment of Metachronous Second Primary Lung Cancer. The Annals of Thoracic Surgery. 2014, 98, no. 4: 1192-1198. DOI: 10.1016/j.athoracsur.2014.05.050
Rzechonek Adam, Piotr Btasiak, Beata Muszczynska-Bernhard et al. Metachronous Lung Cancer: Clinical Characteristics and Effects of Surgical Treatment. Current Concepts in Medical Research and Practice. 2017: 9-17. DOI: 10.1007/5584_2017_82
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.
© АННМО «Вопросы онкологии», Copyright (c) 2020